Cargando…

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

Detalles Bibliográficos
Autores principales: Fattore, Luigi, Malpicci, Debora, Marra, Emanuele, Camerlingo, Rosalba, Roscilli, Giuseppe, Belleudi, Francesca, Ribas, Antoni, Mancini, Rita, Torrisi, Maria Rosaria, Aurisicchio, Luigi, Ascierto, Paolo Antonio, Ciliberto, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315234/
http://dx.doi.org/10.1186/1479-5876-13-S1-K3
_version_ 1782355442621480960
author Fattore, Luigi
Malpicci, Debora
Marra, Emanuele
Camerlingo, Rosalba
Roscilli, Giuseppe
Belleudi, Francesca
Ribas, Antoni
Mancini, Rita
Torrisi, Maria Rosaria
Aurisicchio, Luigi
Ascierto, Paolo Antonio
Ciliberto, Gennaro
author_facet Fattore, Luigi
Malpicci, Debora
Marra, Emanuele
Camerlingo, Rosalba
Roscilli, Giuseppe
Belleudi, Francesca
Ribas, Antoni
Mancini, Rita
Torrisi, Maria Rosaria
Aurisicchio, Luigi
Ascierto, Paolo Antonio
Ciliberto, Gennaro
author_sort Fattore, Luigi
collection PubMed
description
format Online
Article
Text
id pubmed-4315234
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43152342015-02-12 ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors Fattore, Luigi Malpicci, Debora Marra, Emanuele Camerlingo, Rosalba Roscilli, Giuseppe Belleudi, Francesca Ribas, Antoni Mancini, Rita Torrisi, Maria Rosaria Aurisicchio, Luigi Ascierto, Paolo Antonio Ciliberto, Gennaro J Transl Med Keynote Speaker Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315234/ http://dx.doi.org/10.1186/1479-5876-13-S1-K3 Text en Copyright © 2015 Fattore et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Keynote Speaker Presentation
Fattore, Luigi
Malpicci, Debora
Marra, Emanuele
Camerlingo, Rosalba
Roscilli, Giuseppe
Belleudi, Francesca
Ribas, Antoni
Mancini, Rita
Torrisi, Maria Rosaria
Aurisicchio, Luigi
Ascierto, Paolo Antonio
Ciliberto, Gennaro
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
title ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
title_full ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
title_fullStr ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
title_full_unstemmed ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
title_short ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
title_sort erbb3 plays a key role in the early phase of establishment of resistance to braf and/or mek inhibitors
topic Keynote Speaker Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315234/
http://dx.doi.org/10.1186/1479-5876-13-S1-K3
work_keys_str_mv AT fattoreluigi erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT malpiccidebora erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT marraemanuele erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT camerlingorosalba erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT roscilligiuseppe erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT belleudifrancesca erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT ribasantoni erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT mancinirita erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT torrisimariarosaria erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT aurisicchioluigi erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT asciertopaoloantonio erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors
AT cilibertogennaro erbb3playsakeyroleintheearlyphaseofestablishmentofresistancetobrafandormekinhibitors